Pharmaceutical services provider Ergomed announced on Friday a new hire has added specialist pharmacoepidemiology services to its PrimeVigilance drug safety and information offering. The AIM-traded company said it had appointed Michael Forstner, the most recent owner and manager of Swiss-based consultancy Mesama Consulting, as head of risk management and pharmacoepidemiology. Mesama's ongoing contracts will now be assigned to PrimeVigilance. Stephen Stamp, Chief Executive Officer of Ergomed plc, ...Den vollständigen Artikel lesen ...